On 2025-05-12, BioXcel Therapeutics, Inc. (BTAI) announced earnings per share of $-1.50 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-2.72.
The next expected annoucement date for quarterly earnings is 2025-08-05, with an average estimated earnings per share of $-2.24 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-12 | 2025-03-31 | $-2.72 | $-1.50 |
| 2025-03-27 | 2024-12-31 | $-4.36 | $-3.57 |
| 2024-11-14 | 2024-09-30 | $-8.00 | $-5.12 |
| 2024-08-06 | 2024-06-30 | $-12.16 | $-3.36 |
| 2024-05-09 | 2024-03-31 | $-10.88 | $-13.92 |
| 2024-03-12 | 2023-12-31 | $-15.68 | $-12.16 |
| 2023-11-14 | 2023-09-30 | $-20.64 | $-27.52 |
| 2023-08-14 | 2023-06-30 | $-27.52 | $-29.28 |
| 2023-05-08 | 2023-03-31 | $-24.96 | $-29.44 |
| 2023-03-09 | 2022-12-31 | $-23.84 | $-31.20 |
| 2022-11-10 | 2022-09-30 | $-21.44 | $-23.84 |
| 2022-08-09 | 2022-06-30 | $-19.20 | $-21.60 |
| 2022-05-09 | 2022-03-31 | $-19.36 | $-17.92 |
| 2022-03-10 | 2021-12-31 | $-18.88 | $-14.88 |
| 2021-11-10 | 2021-09-30 | $-17.28 | $-15.36 |
| 2021-08-10 | 2021-06-30 | $-16.48 | $-17.76 |
| 2021-05-10 | 2021-03-31 | $-14.24 | $-17.28 |
| 2021-03-11 | 2020-12-31 | $-13.92 | $-13.92 |
| 2020-11-12 | 2020-09-30 | $-12.80 | $-17.12 |
| 2020-08-14 | 2020-06-30 | $-11.84 | $-16.96 |
| 2020-05-12 | 2020-03-31 | $-8.80 | $-12.64 |
| 2020-03-09 | 2019-12-31 | $-10.72 | $-7.20 |
| 2019-11-14 | 2019-09-30 | $-9.44 | $-9.12 |
| 2019-08-06 | 2019-06-30 | $-8.32 | $-8.64 |
| 2019-05-07 | 2019-03-31 | $-7.68 | $-7.36 |
| 2019-03-07 | 2018-12-31 | $-5.44 | $-7.52 |
| 2018-11-09 | 2018-09-30 | $-4.16 | $-4.96 |
| 2018-08-08 | 2018-06-30 | $-5.60 | $-3.04 |
| 2018-05-14 | 2018-03-31 | $-3.36 | $-5.92 |